Results 241 to 250 of about 19,552 (331)

National Prescribing Trends and Cost Analysis of Antidepressants, Anxiolytics, and Hypnotics in England, 2010-2023. [PDF]

Hum Psychopharmacol
Stedman M, Davies M, Levy JW, Ingram J, Taylor D, Heald A.   +5 more
europepmc   +1 more source

Unpacking the link between substance use disorders and 30‐day unplanned readmission

Addiction, Volume 120, Issue 12, Page 2538-2546, December 2025.
Abstract Background and Aims Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30‐day unplanned readmissions, a marker of quality of care.
Allison D. Rosen, Sae Takada, Catherine Juillard, Yulsi L. Fernandez Montero, Amy M. Richards, Serge Ngekeng, Steven J. Shoptaw, Michelle A. Bholat   +7 more
wiley   +1 more source

Correction to: Allostatic load and chronic pain: a prospective finding from the national survey of midlife development in the United States, 2004-2014. [PDF]

BMC Public Health
Liang Y, Booker C.
europepmc   +1 more source

Sedative and Hypnotic [PDF]

, 2020
openaire   +1 more source

Synthesis and Sedative-Hypnotic Activity of Novel N-[3-(3-Aminomethylpyrazolo[1,5- a]pyrimidin-7-yl)phenyl]-N-ethylacetamide Derivatives

, 2013
Yujun Wang, Changwei Song, Xia Li, Ying Li, Shufan Yin   +4 more
openalex   +2 more sources

Counterfeit ‘Xanax®’ tablets: A comparative study of clinical and seizure data in Victoria, Australia

Addiction, Volume 120, Issue 12, Page 2465-2475, December 2025.
Abstract Background and aim There is growing evidence of counterfeit benzodiazepine products containing other substances, including non‐regulated benzodiazepine‐type new psychoactive substances (NPSs). This study sought to compare detections of seized suspect counterfeit alprazolam products with clinical cases that reported use of an alprazolam ...
Rebekka Syrjanen, Shaun L. Greene, Sarah E. Hodgson, Rachelle Abouchedid, Dimitri Gerostamoulos, Christie Magee, Melissa Bremner, Jennifer L. Schumann, on behalf of the Emerging Drugs Network of Australia – Victoria (EDNAV) research group   +8 more
wiley   +1 more source

Risk Factors for Recurrent Fractures in Hip Fracture Patients: A Big Data Analysis of Demographic, Clinical, and Functional Characteristics. [PDF]

J Clin Med
Hershkovitz A, Maydan G, Kornyukov N, Itzhaky Y.   +3 more
europepmc   +1 more source

Existential therapy for treating chronic pain: A scoping review

Applied Psychology: Health and Well-Being, Volume 17, Issue 6, December 2025.
Abstract Integrating an existential lens into chronic pain treatment enables a holistic and biopsychosocial approach to treating chronic pain. This scoping review aimed to identify the characteristics, themes, and results of existential therapy for treating chronic pain.
Amara Kohlert, Natasha L. Gallant, Taylor G. Hill, Kelsy Dabek   +3 more
wiley   +1 more source

Conceptual barriers to palliative sedation: insights from focus group interviews with specialist palliative care professionals. [PDF]

BMC Palliat Care
Torvund S, Thoresen L, Magelssen M, Fredheim OM.   +3 more
europepmc   +1 more source

Nietzsche's Conception of Skepticism as Intellectual Virtue and Vice

European Journal of Philosophy, Volume 33, Issue 4, Page 1466-1485, December 2025.
Abstract Recent approaches are unable to make full sense of Nietzsche's distinction between weak and strong skepticism (BGE 208–209; A54). In this paper, I propose an alternative interpretation. My suggestion is that this distinction is best understood in the context of his virtue epistemology.
Lorenzo Serini
wiley   +1 more source